D. van der Heijde

6.4k citations

58 papers · 2.9k indexed · 3 hit papers · h-index 21

Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 41
- Spondyloarthritis Studies and Treatments 26
- Systemic Lupus Erythematosus Research 10
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research 14
- Chronic Myeloid Leukemia Treatments 4
Immunology top 2%
- Psoriasis: Treatment and Pathogenesis 13
Orthopedics and Sports Medicine top 2%
- Bone and Joint Diseases 7
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 8

Co-authors: Carine Salliot Robert Landewé Naoki Nishimoto Tsutomu Takeuchi Shinichi Kawai Jun Hashimoto N. Miyasaka Tadamitsu Kishimoto
Cited by: Rheumatology Hematology Immunology
Journals: Annals of the Rheumatic Diseases (36 papers)Clinical and Experimental Rheumatology (4 papers)Lara D. Veeken (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

D. van der Heijde

55 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2008 Arthritis & Rheumatism
2008 Annals of the Rheumatic Diseases
2007 Annals of the Rheumatic Diseases

Peers

Countries citing papers authored by D. van der Heijde

Since Specialization

Citations

This map shows the geographic impact of D. van der Heijde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van der Heijde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van der Heijde more than expected).

Fields of papers citing papers by D. van der Heijde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. van der Heijde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van der Heijde. The network helps show where D. van der Heijde may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. van der Heijde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. van der Heijde Line = papers co-authored together D. van der Heijde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discontinuation of Tumor Necrosis Factor Inhibitor Therapy in US Patients with Ankylosing Spondylitis : Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry Data Archiving and Networked Services (DANS) ·Philip J. Mease,D. van der Heijde,Chitra Karki,Jay E Town,Gary Rhoades,Jeffrey D. Greenberg	2017	1
2	CERTOLIZUMAB PEGOL FOR THE TREATMENT OF PSORIATIC ARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-PSA TRIAL Clinical and Experimental Rheumatology ·Philip J. Mease,Roy Fleischmann,J. Wollenhaupt,Atul Deodhar,Dafna D. Gladman,Bengt Hoepken,Luke Peterson,D. van der Heijde	2016	2
3	Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the EULAR Recommendations for the Management of PSA Data Archiving and Networked Services (DANS) ·S. Ramiro,J S Smolen,Robert Landewé,D. van der Heijde,Maxime Dougados,Paul Emery,Maarten de Wit,矢嶋祥子,Sandy Oliver,Laure Gossec	2015	1
4	Oskira-1: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Methotrexate Data Archiving and Networked Services (DANS) ·M. Weinblatt,Mark C. Genovese,M. Ho,Léni Nina Débora Ezin Aloffan,Rebecka Nelson,Arthur Kavanaugh,David Millson,G. Léon,عبدالرضا رکن¬الدین افتخاری,D. van der Heijde	2013	7
5	Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol Annals of the Rheumatic Diseases ·D. van der Heijde,Roy Fleischmann,J. Wollenhaupt,Atul Deodhar,Danuta Kielar,Franz Woltering,C. Stach,Bengt Hoepken,T. Arledge,Philip J. Mease	2013	60
6	Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study Arthritis & Rheumatism ·D. van der Heijde,Yoshiya Tanaka,R Fleischmann,Edward Keystone,J.M. Kremer,Cristiano A. F. Zerbini,Mario H. Cardiel,S. Cohen,Peter Nash,Yu Song,Dana Tegzová,Bradley T. Wyman,David Gruben,Birgitta Benda,Gene V. Wallenstein,S. Krishnaswami,Samuel H. Zwillich,John Bradley,Carol A. Connell,Gurieva Ugra	2012	4
7	Improvement in Physical Function, Health-Related Quality of Life, and Work Productivity with Adalimumab Treatment in Nonradiographic Axial Spa: Wk-52 Results From Ability-1 Arthritis & Rheumatism ·D. van der Heijde,Delgado Domínguez,П. В. Михалёв,Smitha Rao,G. Myers,G Yao	2012	1
8	DISEASE BURDEN IS COMPARABLE IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKLOYSING SPONDYLITIS PATIENTS : TREATMENT IMPLICATIONS Clinical and Experimental Rheumatology ·J. Sieper,D. van der Heijde,Dirk Elewaut,П. В. Михалёв,John Anderson	2012	1
9	Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE) Lara D. Veeken ·D. van der Heijde,Joseph M. Braun,Z R M Nkhungulu,Robert D. Inman,Shancai Xu,M. Mack,Benjamin Hsu	2012	24
10	EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS : 3-YEAR DATA FROM THE RAPID 2 STUDY Lara D. Veeken ·Josef S Smolen,Ronald van Vollenhoven,Arthur Kavanaugh,Andreas Fichtner,Vibeke Strand,Jiří Vencovský,D. van der Heijde	2011	2
11	RADIOGRAPHIC FINDINGS AFTER 5 YEARS OF INFLIXIMAB TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS Clinical and Experimental Rheumatology ·Xenofon Baraliakos,F. Heldmann,D. van der Heijde,Joachim Listing,Joachim Sieper,Alessandra Oortwijn,Rebecca Bolce,Jürgen Braun	2010	1
12	Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis Annals of the Rheumatic Diseases ·E. Lie,D. van der Heijde,T. Uhlig,Marte Schrumpf Heiberg,Wenche Koldingsnes,E Rødevand,C. Kaufmann,K. Mikkelsen,T.K. Kvien	2009	88
13	Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature researchbreakdown → Annals of the Rheumatic Diseases ·Carine Salliot,D. van der Heijde	2008	487
14	Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study Annals of the Rheumatic Diseases ·Ingiäld Hafström,Kristina Albertsson,Annelies Boonen,D. van der Heijde,Robert Landewé,Björn Svensson	2008	67
15	Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-α blocking agents Annals of the Rheumatic Diseases ·Qianyin Zheng,Espen A. Haavardsholm,Sylvie Pollmann,Annelies Boonen,D. van der Heijde,Tore K Kvien,Øyvind Molberg	2008	49
16	Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanerceptbreakdown → Arthritis & Rheumatism ·D. van der Heijde,Robert Landewé,Steven Einstein,P A Ory,Debby Vosse,L. Ni,Mukesh Thakur,Wayne Tsuji,John C. Davis	2008	408
17	Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis Annals of the Rheumatic Diseases ·V.K. Moselakgomo,Sigrid Ødegård,Magne K. Fagerhol,Robert Landewé,D. van der Heijde,T. Uhlig,Petter Mowinckel,Tore K Kvien	2007	124
18	Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose Annals of the Rheumatic Diseases ·E.D. Boerner,Jean‐Pierre Devogelaer,Kalden,John J Fitzpatrick,Paul Emery,Byung-Ju Kim,D. van der Heijde,Ed Keystone,최정해,Kalpana Patel,Jung-Yong Han,J. Smolen,Andrew S. Ng	2004	4
19	The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·J. Smolen,D. van der Heijde,Jean‐Pierre Devogelaer,Jean-Yves Anglade,M Bala,최정해,Jung-Yong Han,M Bauzon	2004	2
20	Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis? Annals of the Rheumatic Diseases ·Annelies Boonen,D. van der Heijde,Robert Landewé,A.M.J. Chorus,Wim van Lankveld,Harald S. Miedema,Hille van der Tempel,S van der Linden	2004	17

About D. van der Heijde

D. van der Heijde is a scholar working on Rheumatology, Hematology and Immunology, having authored 58 papers that have together received 2.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (41 papers), Spondyloarthritis Studies and Treatments (26 papers), Autoimmune and Inflammatory Disorders Research (14 papers), Psoriasis: Treatment and Pathogenesis (13 papers), Systemic Lupus Erythematosus Research (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Bone and Joint Diseases (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Rheumatology (2.4k citations), Hematology (951 citations) and Immunology (955 citations). D. van der Heijde has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Carine Salliot, Robert Landewé, Naoki Nishimoto, Tsutomu Takeuchi, Shinichi Kawai, Jun Hashimoto, N. Miyasaka, Tadamitsu Kishimoto, N. Murata and Kazuhiko Yamamoto. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical and Experimental Rheumatology, Lara D. Veeken, RMD Open and Arthritis & Rheumatism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact